Alternative splicing of tumor suppressors and oncogenes

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Alternative splicing is crucial for regulating gene expression in response to various stimuli.
• Errors in alternative splicing are increasingly linked to cancer progression.
• These errors stem from mutations in cis-acting elements or imbalances in trans-acting factors.

Purpose of the Study:

• To explore the intricate relationship between alternative splicing and signal transduction pathways in cancer.
• To highlight the central role of splicing factors as both targets and effectors in regulatory circuits.
• To provide examples of how deregulated alternative splicing contributes to tumor progression.

Main Methods:

• Review of existing literature and case studies.
• Analysis of molecular mechanisms linking splicing factors to signal transduction.
• Examination of alternative splicing profiles in tumor samples.

Main Results:

• Alternative splicing events are tightly integrated with signal transduction pathways.
• Splicing factors are critical nodes in these networks, influencing cell behavior.
• Dysregulation of alternative splicing is a common feature in various tumors.

Conclusions:

• Altered activity of splicing factors significantly impacts alternative splicing patterns.
• Deregulated alternative splicing is a key driver in tumor progression.
• Understanding these mechanisms offers potential therapeutic targets for cancer treatment.